US Patent Issued to LISCure Bio on Aug. 11 for "Pharmaceutical composition for preventing or treating cholestatic liver injury comprising Leuconostoc citreum strain as active ingredient" (South Korean Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,687, issued on Aug. 11, was assigned to LISCure Bio Inc. (Seongnam-si, South Korea).

"Pharmaceutical composition for preventing or treating cholestatic liver injury comprising Leuconostoc citreum strain as active ingredient" was invented by Hwa Sup Chin (Yongin-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition comprising a Leuconostoc citreum strain or its culture as an active ingredient for preventing, improving or treating cholestatic liver injury, specifically primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). According to the present invention, since the compositi...